|
|
|
Insider
Information: |
Kirk Randal J |
Relationship: |
10% Owner |
City: |
Radford |
State: |
VA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
3,684,697 |
|
Indirect Shares
|
67,796,291 |
|
|
Direct
Value |
$162,251,771 |
|
|
Indirect Value
|
$375,195,594 |
|
|
Total
Shares |
71,480,988 |
|
|
Total
Value |
$537,447,365 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
0
|
Stock
price went up :
|
6
|
0
|
Stock
price went down : |
8
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
46.5%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-28 |
4 |
B |
$2.56 |
$153,600 |
I/I |
60,000 |
475,300 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-29 |
4 |
B |
$2.60 |
$59,800 |
I/I |
23,000 |
498,300 |
1.5 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-22 |
4 |
B |
$12.30 |
$49,348 |
I/I |
4,012 |
512,762 |
2.25 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2021-11-22 |
4 |
B |
$3.52 |
$739,979 |
I/I |
206,004 |
513,665 |
2.25 |
% |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-09-06 |
4 |
B |
$2.56 |
$44,288 |
I/I |
17,300 |
515,600 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2007-03-14 |
4 |
B |
$7.91 |
$238,882 |
I/I |
30,200 |
522,460 |
1.5 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-23 |
4 |
B |
$12.97 |
$162,125 |
I/I |
12,500 |
525,262 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-09-07 |
4 |
B |
$2.51 |
$37,650 |
I/I |
15,000 |
530,600 |
1.5 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-24 |
4 |
B |
$13.17 |
$140,827 |
I/I |
10,693 |
535,955 |
2.25 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-25 |
4 |
B |
$13.48 |
$103,756 |
I/I |
7,697 |
543,652 |
2.25 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-28 |
4 |
B |
$15.07 |
$210,829 |
I/I |
13,990 |
557,642 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2008-06-20 |
4 |
B |
$5.85 |
$1,026,675 |
I/I |
175,500 |
558,191 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-09-08 |
4 |
B |
$2.52 |
$76,860 |
I/I |
30,500 |
561,100 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-09-11 |
4 |
B |
$2.54 |
$8,128 |
I/I |
3,200 |
564,300 |
1.5 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-29 |
4 |
B |
$15.00 |
$189,315 |
I/I |
12,621 |
570,263 |
2.25 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2016-01-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,305,354 |
577,319 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-09-12 |
4 |
B |
$2.58 |
$51,600 |
I/I |
20,000 |
584,300 |
1.5 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-09-06 |
4 |
B |
$14.95 |
$627,900 |
I/I |
42,000 |
612,263 |
2.25 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-09-13 |
4 |
B |
$15.42 |
$471,405 |
I/I |
30,571 |
642,834 |
2.25 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2012-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
3,000,000 |
649,181 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-09-13 |
4 |
B |
$2.50 |
$185,000 |
I/I |
74,000 |
658,300 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-09-14 |
4 |
B |
$2.50 |
$50,000 |
I/I |
20,000 |
678,300 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-08-09 |
4 |
B |
$5.88 |
$4,341,386 |
I/I |
738,331 |
738,331 |
2.25 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2014-05-09 |
4 |
B |
$13.42 |
$202,481 |
I/I |
15,088 |
779,294 |
2.64 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-09-15 |
4 |
B |
$2.50 |
$256,250 |
I/I |
102,500 |
780,800 |
1.5 |
- |
|
271 Records found
|
|
Page 4 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|